Critical illness polyneuropathy

Current Opinion in Neurology

Volumn 14, Issue 5, 2001, Pages 649-653

  Hund, E ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL VENTILATION; CLINICAL FEATURE; CRITICAL ILLNESS; DIFFERENTIAL DIAGNOSIS; ELECTRODIAGNOSIS; HUMAN; INFLAMMATION; MULTIPLE ORGAN FAILURE; MUSCLE ATROPHY; MUSCLE WEAKNESS; NEUROPATHY; PATHOGENESIS; POLYNEUROPATHY; PROGNOSIS; REVIEW; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

DIAGNOSIS, DIFFERENTIAL; HUMANS; POLYNEUROPATHIES;

EID: 0034800689     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200110000-00015     Document Type: Review

References (53)

1. Treating patients with severe sepsis
2. Neuromuscular complications in the ICU: The spectrum of critical illness-related conditions causing muscular weakness and weaning failure
3. Sepsis and the systemic inflammatory response syndrome: Neuromuscular manifestations
4. Lesions of peripheral nerves developing during coma
5. Die disseminierte neuropathie nach koma
6. Critical illness polyneuromyopathy after artificial respiration
7. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure
8. Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator
9. Polyneuropathies in critically ill patients: A prospective evaluation
10. Critical illness myopathy and neuropathy
11. Predominant involvement of motor fibres in patients with critical illness polyneuropathy
12. Patterns of neurophysiological abnormality in prolonged critical illness
13. Critical illness polyneuropathy
14. Peripheral nerve function in sepsis and multiple organ failure
15. Critical illness neuropathy in pediatric intensive care patients
16. Clinical and electrophysiological findings in critical illness polyneuropathy
17. Critical illness polyneuropathy: Clinical findings and outcomes of a frequent cause of neuromuscular weaning failure
18. Suxamethonium and critical illness polyneuropathy
19. Critically ill polyneuropathy: Electrophysiological studies and differentiation from Guillain-Barré syndrome
20. Neuromuscular complications of sepsis
21. Acute respiratory failure neuropathy: A variant of critical illness polyneuropathy
22. Critical illness polyneuropathy due to parenteral nutrition
23. A useful concept
24. The epidemiology of the systemic inflammatory response
25. Sepsis/septic shock: Participation of the microcirculation: An abbreviated review
26. Preliminary observations on the neuromuscular abnormalities in patients with organ failure and sepsis
27. A humoral neurotoxic factor in sera of patients with critical illness polyneuropathy
28. Critical illness polyneuropathy and myopathy (CIPNM): Evidence for local immune activation by cytokine-expression in the muscle tissue
29. Prognosis in acute organ-system failure
30. The neurological complications of sepsis
31. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation
32. Long-term outcome of critical illness polyneuropathy
33. Acute neuromuscular respiratory paralysis
34. Chemotherapy-induced peripheral neuropathy
35. Zytostatikainduzierte polyneuropathien
36. The porphyrias
37. Infective endocarditis with inflammatory lesions in the peripheral nervous system
38. Distinctions between critical illness polyneuropathy and axonal Guillain-Barré syndrome
39. Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: A review of the literature
40. Persistent paralysis in critically ill patients after long-term administration of vecuronium
41. Acute weakness syndromes in the critically ill patient
42. Muscle dysfunction in the intensive care unit
43. Myasthenia gravis and Lambert-Eaton myasthenic syndrome
44. Drugs and toxins associated with myopathies
45. Myopathy in critically ill patients
46. Direct muscle stimulation in acute quadriplegic myopathy
47. Critical care myopathy: An electrophysiological and histological study
48. Causes of neuromuscular weakness in the intensive care unit: A study of ninety-two patients
49. Acute necrotizing myopathy of intensive care: Electrophysiological studies
50. Neuromuscular blockade in the intensive care unit: More than we bargained for
51. Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and Gram-negative sepsis
52. Intravenous immunoglobulin for treating sepsis and septic shock